Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconTECHBIO-TECHNE$7.97bn41.750.62%
us flag iconCRLCharles River Laboratories International$7.52bn47.34n/a
us flag iconRGCRegencell Bioscience Holdings$7.27bnn/an/a
us flag iconRETAReata Pharmaceuticals$6.52bnn/an/a
us flag iconCYTKCytokinetics$6.12bnn/an/a
us flag iconLEGNLegend Biotech$6.11bnn/an/a
us flag iconNUVLNuvalent$5.80bnn/an/a
us flag iconISEEIVERIC bio$5.51bnn/an/a
us flag iconMRUSMerus NV$5.26bnn/an/a
us flag iconCRSPCrispr Therapeutics AG$5.12bnn/an/a
us flag iconMENSJyong Biotech$4.68bnn/an/a
us flag iconSYNHSyneos Health$4.46bn28.55n/a
us flag iconALPNAlpine Immune Sciences$4.46bnn/an/a
us flag iconALKSAlkermes$4.45bn12.95n/a
us flag iconACLXArcellx$4.23bnn/an/a
us flag iconPCVXVaxcyte$4.18bnn/an/a
us flag iconKRYSKrystal Biotech$4.16bn27.14n/a
us flag iconMRTXMirati Therapeutics$4.12bnn/an/a
us flag iconARWRArrowhead Pharmaceuticals$4.11bnn/an/a
us flag iconALKSVAlkermes$4.05bn18.02n/a